piribedil has been researched along with Chronic Insomnia in 1 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixteen patients with symptoms of restless legs syndrome and resulting insomnia are included in this study." | 2.66 | Restless legs syndrome treatment with dopaminergic drugs. ( Akpinar, S, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akpinar, S | 1 |
1 trial available for piribedil and Chronic Insomnia
| Article | Year |
|---|---|
Restless legs syndrome treatment with dopaminergic drugs.
Topics: Adult; Aged; Benserazide; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Female; Huma | 1987 |